Rebuilding Joint Surface to Prevent Pain and Immobility

Akronym

RePace

Bidragets beskrivning

A healthy layer of articular cartilage at the end of bones in joints is essential for painless movement. When cartilage is damaged, it has minimal innate regenerative properties and there is no effective medical cure. Cartilage damage seriously reduce quality of life and has severe economic impact since loss of cartilage leads to osteoarthritis (OA) that causes hundreds of billions of Euros healthcare and related costs annually. Many attempts have been made to restore joint surface cartilage, but the tissue has shown to be extremely difficult to rebuild. Askel has developed a unique way to rebuild joint surfaces for pain-free movement. COPLA® is a biodegradable implant that creates a weight-adaptive microenvironment in the damaged site enabling quick rehabilitation and cartilage regeneration to prevent OA. COPLA® will become the Gold Standard for early cartilage repair with rapid recovery and long-term results, ensuring pain-free movement, high quality of life and prevention of OA.
Visa mer

Startår

2022

Slutår

2024

Beviljade finansiering

ASKEL HEALTHCARE OY
Coordinator

Beviljat belopp

2 499 000 €

Finansiär

Europeiska unionen

Typ av finansiering

HORIZON EIC Accelerator Blended Finance

Ramprogram

Horizon Europe (HORIZON)

Utlysning

Programdel
The European Innovation Council (EIC) (11739)
The Accelerator (11741)
Tema
EIC Accelerator Open 2021 (HORIZON-EIC-2021-ACCELERATOROPEN-01)
Utlysnings ID
HORIZON-EIC-2021-ACCELERATOROPEN-01

Övriga uppgifter

Finansieringsbeslutets nummer

190102649